197 related articles for article (PubMed ID: 35844650)
1. Novel Coumarin-Pyridine Hybrids as Potent Multi-Target Directed Ligands Aiming at Symptoms of Alzheimer's Disease.
Babaei E; Küçükkılınç TT; Jalili-Baleh L; Nadri H; Öz E; Forootanfar H; Hosseinzadeh E; Akbari T; Ardestani MS; Firoozpour L; Foroumadi A; Sharifzadeh M; Mirjalili BBF; Khoobi M
Front Chem; 2022; 10():895483. PubMed ID: 35844650
[TBL] [Abstract][Full Text] [Related]
2. Development of the "hidden" multi-target-directed ligands by AChE/BuChE for the treatment of Alzheimer's disease.
Chen R; Li X; Chen H; Wang K; Xue T; Mi J; Ban Y; Zhu G; Zhou Y; Dong W; Tang L; Sang Z
Eur J Med Chem; 2023 May; 251():115253. PubMed ID: 36921526
[TBL] [Abstract][Full Text] [Related]
3. New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease.
El-Sayed NF; El-Hussieny M; Ewies EF; Fouad MA; Boulos LS
Bioorg Chem; 2020 Jan; 95():103499. PubMed ID: 31838287
[TBL] [Abstract][Full Text] [Related]
4. Chromone derivatives bearing pyridinium moiety as multi-target-directed ligands against Alzheimer's disease.
Abdpour S; Jalili-Baleh L; Nadri H; Forootanfar H; Bukhari SNA; Ramazani A; Ebrahimi SES; Foroumadi A; Khoobi M
Bioorg Chem; 2021 May; 110():104750. PubMed ID: 33691251
[TBL] [Abstract][Full Text] [Related]
5. Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease.
Unzeta M; Esteban G; Bolea I; Fogel WA; Ramsay RR; Youdim MB; Tipton KF; Marco-Contelles J
Front Neurosci; 2016; 10():205. PubMed ID: 27252617
[TBL] [Abstract][Full Text] [Related]
6. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N
Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578
[TBL] [Abstract][Full Text] [Related]
7. Novel tetrahydroacridine derivatives with iodobenzoic acid moiety as multifunctional acetylcholinesterase inhibitors.
Skibiński R; Czarnecka K; Girek M; Bilichowski I; Chufarova N; Mikiciuk-Olasik E; Szymański P
Chem Biol Drug Des; 2018 Feb; 91(2):505-518. PubMed ID: 28944565
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Pan W; Wang K; Ma Q; Yu L; Yang Y; Bai P; Leng C; Xu Q; Li X; Tan Z; Liu W
Eur J Med Chem; 2017 Apr; 130():379-392. PubMed ID: 28279845
[TBL] [Abstract][Full Text] [Related]
9. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
[TBL] [Abstract][Full Text] [Related]
10. Chromone-lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities.
Jalili-Baleh L; Nadri H; Forootanfar H; Küçükkılınç TT; Ayazgök B; Sharifzadeh M; Rahimifard M; Baeeri M; Abdollahi M; Foroumadi A; Khoobi M
Daru; 2021 Jun; 29(1):23-38. PubMed ID: 33420969
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's disease.
Liu W; Wu L; Liu W; Tian L; Chen H; Wu Z; Wang N; Liu X; Qiu J; Feng X; Xu Z; Jiang X; Zhao Q
Eur J Med Chem; 2022 Nov; 242():114689. PubMed ID: 36007469
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
[TBL] [Abstract][Full Text] [Related]
13. New classes of carbazoles as potential multi-functional anti-Alzheimer's agents.
Choubdar N; Golshani M; Jalili-Baleh L; Nadri H; Küçükkilinç TT; Ayazgök B; Moradi A; Moghadam FH; Abdolahi Z; Ameri A; Salehian F; Foroumadi A; Khoobi M
Bioorg Chem; 2019 Oct; 91():103164. PubMed ID: 31398601
[TBL] [Abstract][Full Text] [Related]
14. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J
Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer's disease.
Meena P; Nemaysh V; Khatri M; Manral A; Luthra PM; Tiwari M
Bioorg Med Chem; 2015 Mar; 23(5):1135-48. PubMed ID: 25624107
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of New 3-Arylcoumarins Bearing
Pourabdi L; Küçükkılınç TT; Khoshtale F; Ayazgök B; Nadri H; Farokhi Alashti F; Forootanfar H; Akbari T; Shafiei M; Foroumadi A; Sharifzadeh M; Shafiee Ardestani M; Abaee MS; Firoozpour L; Khoobi M; Mojtahedi MM
Front Chem; 2021; 9():810233. PubMed ID: 35127652
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease.
Brunetti L; Leuci R; Carrieri A; Catto M; Occhineri S; Vinci G; Gambacorta L; Baltrukevich H; Chaves S; Laghezza A; Altomare CD; Tortorella P; Santos MA; Loiodice F; Piemontese L
Eur J Med Chem; 2022 Jul; 237():114358. PubMed ID: 35462163
[TBL] [Abstract][Full Text] [Related]
18. Novel Cyclopentaquinoline and Acridine Analogs as Multifunctional, Potent Drug Candidates in Alzheimer's Disease.
Maciejewska K; Czarnecka K; Kręcisz P; Niedziałek D; Wieczorek G; Skibiński R; Szymański P
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682556
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease.
Yu YF; Huang YD; Zhang C; Wu XN; Zhou Q; Wu D; Wu Y; Luo HB
ACS Chem Neurosci; 2017 Nov; 8(11):2522-2534. PubMed ID: 28783948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
